Keep Your Voice Strong

Many other columnists have noted the high cost of Donald Trump’s tariff policies. With that said, it’s also important to credit the president with an important win for free trade and property rights, notes James Freeman in the WSJ.

Foreign bureaucrats in socialist health systems are not practicing free trade when they force American medical innovators to accept low prices for their creations.

Kudos to President Trump for what could turn out to be a milestone reform.

Just Plain Wrong

Much of what politicians have told you about drug prices is wrong, reports the Journal.

Many pols rail about how U.S. inventors of new medicines often make most of their profits in the U.S., even as they sell their creations worldwide. But just because U.S. companies are not making big profits overseas doesn’t mean no one is. What many foreign governments do is force the U.S. inventors to accept low prices and then allow generic producers… to charge higher prices than U.S. entitlement programs pay for generics in the U.S. It’s a perfect scam—transferring wealth from innovators to copycats, and in many cases from U.S. companies to foreign firms.

James Freeman’s ambitions are high:

Let’s hope that more of the President’s trade disputes conclude with zero tariffs and fewer governments dictating prices.

Orginally posted December 3rd, 2025